Healthcare -
Biotechnology - NASDAQ - US
$ 0.6581
-0.903 %
$ 83 M
Market Cap
-0.63
P/E
KPTI - SHORT-TERM DEBT
Short-term Debt KPTI - Karyopharm Therapeutics Inc.
3.31 M
LAST VALUE
-15.49%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR